For the Inventor, By the Inventor

Enter assignee name

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USPTO Granted Patents = 15

EPO Patents = 12

Forward Citations = 14

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Ningshao Xia (15 out of 54 patents)

Shaowei Li (11 out of 26 patents)

Jun Zhang (9 out of 109 patents)

4. Ying Gu (8 out of 16 patents)

5. Shengxiang Ge (6 out of 13 patents)

6. Zhiqiang He (5 out of 5 patents)

7. Xiangzhong Ye (4 out of 6 patents)

8. Hua Zhu (3 out of 5 patents)

9. Yimin Li (3 out of 3 patents)

10. Tong Cheng (3 out of 6 patents)

11. Huirong Pan (3 out of 7 patents)

12. Chunyan Yang (2 out of 6 patents)

13. Jin Wang (2 out of 8 patents)

14. Bo Liu (2 out of 5 patents)

15. Ji Miao (2 out of 3 patents)

15 patents: Sort by Forward Citations

1. 11220673 - ORF7 deficient varicella virus, vaccine comprising the virus and use thereof (2022-01-11),

2. 10864521 - Detection mechanism for polymerase chain reaction and polymerase chain reaction device (2020-12-15),

3. 10752885 - ORF7 deficient varicella virus, vaccine comprising the virus and use thereof (2020-08-25),

4. 9943586 - Truncated L1 protein of human papillomavirus type 11 (2018-04-17),

5. 9885020 - ORF7 deficient varicella virus, vaccine comprising the virus and use thereof (2018-02-06),

6. 9745351 - Truncated L1 protein of human papillomavirus type 6 (2017-08-29),

7. 9533035 - Truncated L1 protein of human papillomavirus type 11 (2017-01-03),

8. 9428555 - Truncated L1 protein of Human Papillomavirus type 16 (2016-08-30),

9. 9428554 - Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof (2016-08-30),

10. 9364529 - Truncated L1 protein of human papillomavirus type 18 (2016-06-14),

11. 8748127 - Truncated L1 protein of human papillomavirus type 6 (2014-06-10),

12. 8715695 - Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits (2014-05-06),

13. 8524868 - Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits (2013-09-03),

14. 7786264 - Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof (2010-08-31),

15. 7615228 - Polypeptide fragments of hepatitis E virus, the vaccine comprising said fragments and the diagnostic kits (2009-11-10),

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a leading Chinese biopharmaceutical company specializing in the research, development, production, and marketing of diagnostic reagents and therapeutic biological products. With a commitment to innovation, Wantai is dedicated to ensuring high-quality products that meet international standards. The company has a strong global presence and is recognized for its significant contributions to the healthcare industry through its advanced testing solutions and pharmaceutical portfolio.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#174 in Beijing

#1,708 in China

#38,719 in the World

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Forward Citations = 14

27 inventors:

Ningshao Xia (15 out of 54 patents)

Shaowei Li (11 out of 26 patents)

Jun Zhang (9 out of 109 patents)

4. Ying Gu (8 out of 16 patents)

5. Shengxiang Ge (6 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…